Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.23 USD | +1.44% | +7.62% | +52.38% |
May. 31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
May. 21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.38% | 960M | |
+18.00% | 123B | |
+17.06% | 111B | |
-9.02% | 23.63B | |
+4.66% | 22.58B | |
-37.63% | 17.61B | |
-8.83% | 17.6B | |
-15.36% | 17.26B | |
+4.45% | 13.55B | |
+28.67% | 11.34B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Immunome Completes Purchase of Antibodies From Atreca